Everist Genomics, Inc.
|Everist Genomics, Inc. Patent applications|
|Patent application number||Title||Published|
|20120185174||Prognostic Signature for Colorectal Cancer Recurrance - An assay system is useful for predicting recurrence and/or non-recurrence of colorectal cancer in a patient. The assay system is adapted to analyze a patient sample for quantitative expression of a prognostic genetic profile correlated with colorectal cancer recurrence. The profile includes the expression of the nucleic acid sequences of SEQ ID NOS: 1, 2, 3, 4, and 5.||07-19-2012|